Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.
G
20,09%
3-year Growth Rate
R
0/0
3-year Risk Analysis
O
6,48%
Outlook 12/26
W
42,79%
Margin of safety
T
47,31%
Analyst Price Target
H
DOWN
50-week EMA Trend
It is not possible to show the GROWTH analysis for a period of five years. Showing the analysis for a period of three years instead.
Company Info
EPS Growth 5Y
14,13%
Revenue growth 5Y
26,33%
Price growth 5Y
7,04%
Market Cap
HK$30,34 B
Long-Term Debt
HK$0,00 B
Annual earnings
03/26/2026 (A)
Dividend
HK$1,31
Dividend Yield
4,60%
Industry
Country
Website
ISIN Number
Giant Biogene Holding Price Chart
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
HK$42,10
47.31%
Last Update: 03/26/2026
Analysts: 17
Highest Price Target HK$82,20
Average Price Target HK$42,10
Lowest Price Target HK$33,93
Top growth stocks in the health care sector
| Stock | Rate of Return 5Y | Price 5Y | Div. 5Y | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|---|---|
|
Giant Biogene Holding
SEHK:2367
|
15,58% | 7,04% | 8,54% | 20,09% | 0/0 | 6,48% | 42,79% | 47,31% | DOWN |
